GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLF) » Definitions » 5-Year ROIIC %

ANSLF (Ansell) 5-Year ROIIC % : -21.85% (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Ansell 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Ansell's 5-Year ROIIC % for the quarter that ended in Jun. 2024 was -21.85%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Ansell's 5-Year ROIIC % or its related term are showing as below:

ANSLF's 5-Year ROIIC % is ranked worse than
68.97% of 780 companies
in the Medical Devices & Instruments industry
Industry Median: 0.035 vs ANSLF: -21.85

Ansell 5-Year ROIIC % Historical Data

The historical data trend for Ansell's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ansell 5-Year ROIIC % Chart

Ansell Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.19 20.76 14.06 -3.63 -21.85

Ansell Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.06 - -3.63 - -21.85

Competitive Comparison of Ansell's 5-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Ansell's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ansell's 5-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Ansell's 5-Year ROIIC % falls into.



Ansell 5-Year ROIIC % Calculation

Ansell's 5-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( 40.4271 (Jun. 2024) - 129.55666 (Jun. 2019) )/( 2058.9 (Jun. 2024) - 1753.8 (Jun. 2019) )
=-89.12956/305.1
=-29.21%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Ansell  (OTCPK:ANSLF) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Ansell 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Ansell's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ansell Business Description

Traded in Other Exchanges
Address
678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell Headlines

From GuruFocus

Half Year 2020 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Ansell Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Ansell Ltd FY22 Guidance and Trading Update Transcript

By GuruFocus Research 02-12-2024

Half Year 2019 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Ansell Ltd Sustainability Briefing Transcript

By GuruFocus Research 02-12-2024

PPE Manufacturer Ansell Still Trading at a Nice Valuation

By Holmes Osborne, CFA Holmes Osborne, CFA 05-19-2021

Ansell Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Ansell Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Half Year 2024 Ansell Ltd Earnings Presentation Transcript

By GuruFocus Research 09-13-2024

Full Year 2021 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024